Canada Pension Plan Investment Board’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
Canada Pension Plan Investment Board's TXG Position: Q1 2026 in Review
Canada Pension Plan Investment Board reduced its 10x Genomics (TXG) stake by 64% in Q1 2026, selling an estimated $2.93M and leaving 82,900 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #927.
Canada Pension Plan Investment Board first reported a position in TXG in Q1 2021 and has held it in 14 quarters since. The position peaked at $3.74M in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- Canada Pension Plan Investment Board held 82,900 shares of 10x Genomics worth $1.76M as of Q1 2026.
- Canada Pension Plan Investment Board sold 146,400 10x Genomics shares in Q1 2026, an estimated $2.93M.
- 10x Genomics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #927 holding.
- Canada Pension Plan Investment Board first reported a position in 10x Genomics in Q1 2021 and has held it in 14 quarters since.
- Canada Pension Plan Investment Board's 10x Genomics position peaked at $3.74M in Q4 2025.
- 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.